References
- Dalton SO, Frederiksen BL, Jacobsen E, et al. Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001–2008. Br J Cancer. 2011;105:1042–1048.
- Dalton SO, Steding-Jessen M, Engholm G, et al. Social inequality and incidence of and survival from lung cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer. 2008;44:1989–1995.
- Dalton SO, Steding-Jessen M, Jakobsen E, et al. Socioeconomic position and survival after lung cancer: influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004–2010. Acta Oncol. 2015;54:797–804.
- Marquez-Medina D, Martin-Marco A, Ojanguren-Garranz A. Age does not worsen the efficacy nor tolerance to combined induction therapies in locally advanced non-small cell lung cancer. Anticancer Res. 2014;34:4373–4376.
- Wong J, Xu B, Yeung HN, et al. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014;90:224–230.
- Semrau S, Zettl H, Hildebrandt G, et al. Older patients with inoperable non-small cell lung cancer: long-term survival after concurrent chemoradiotherapy. Strahlenther Onkol. 2014;190:1125–1132.
- Freund KM, Battaglia TA, Calhoun E, et al. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst. 2014;106:dju115.
- Battaglia TA, Darnell JS, Ko N, et al. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat. 2016;158:523–534.
- Jean-Pierre P, Cheng Y, Wells KJ, et al. Satisfaction with cancer care among underserved racial-ethnic minorities and lower-income patients receiving patient navigation. Cancer. 2016;122:1060–1067.
- Ko NY, Snyder FR, Raich PC, et al. Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program. Cancer. 2016;122:2715–2722.
- Rodday AM, Parsons SK, Snyder F, et al. Impact of patient navigation in eliminating economic disparities in cancer care. Cancer. 2015;121:4025–4034.
- Baik SH, Gallo LC, Wells KJ. Patient navigation in breast cancer treatment and survivorship: a systematic review. J Clin Oncol. 2016;34:3686–3696.
- Krok-Schoen JL, Oliveri JM, Paskett ED. Cancer care delivery and women's health: the role of patient navigation. Front Oncol. 2016;6:2.
- Tho PC, Ang E. The effectiveness of patient navigation programs for adult cancer patients undergoing treatment: a systematic review. JBI Database System Rev Implement Rep. 2016;14:295–321.
- Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer. 1994;30A:635–642.
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
- Schwarzer RJ. Generalized Self-efficacy scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: a user's portfolio. Causal and control beliefs. Windsor, Berkshire: NFER-NELSON; 1995. p. 35–7.
- Hibbard JH, Stockard J, Mahoney ER, et al. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39:1005–1026.
- Stensland KD, McBride RB, Latif A, et al. Adult cancer clinical trials that fail to complete: an epidemic? J Natl Cancer Inst. 2014;106:dju229. doi: 10.1093/jnci/dju229.
- Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109–2117.
- Grose D, Morrison DS, Devereux G, et al. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment. Postgrad Med J. 2014;90:305–310.
- Hastert TA, Ruterbusch JJ, Beresford SA, et al. Contribution of health behaviors to the association between area-level socioeconomic status and cancer mortality. Soc Sci Med. 2016;148:52–58.
- Brintnall-Karabelas J, Sung S, Cadman ME, et al. Improving recruitment in clinical trials: why eligible participants decline. J Empir Res Hum Res Ethics. 2011;6:69–74.
- Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112:228–242.
- Grand MM, O'brien PC. Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature. J Med Imaging Radiat Oncol. 2012;56:31–39.
- Kauffman KS, Dosreis S, Ross M, et al. Engaging hard-to-reach patients in patient-centered outcomes research. J Comp Eff Res. 2013;2:313–324.
- Keusch F, Rao R, Chang L, et al. Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:1604–1611.
- Shaghaghi A, Bhopal RS, Sheikh A. Approaches to recruiting “opulations into Re-search: a review of the literature” populations into. Health Promot Perspect. 2011;1:86–94.
- Hamilton DW, de Salis I, Donovan JL, et al. The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer. Eur Arch Otorhinolaryngol. 2013;270:2333–2337.
- Park ER, Weiss ES, Moy B. Recruiting and enrolling minority patients to cancer clinical trials. Commun Oncol. 2007;4:254–257.